The current study is designed to explore the possibility of quantifying anti-HBc, a non-neutralizing antibody generated by host immune system in response to chronic hepatitis B infection, as a potential predictive marker of subsequent spontaneous HBsAg seroclearance. This evidence concerns the gene KRT88P and chronic hepatitis B virus infection.